Literature DB >> 2874293

HLA-DR in Lyme borreliosis.

W Kristoferistsch, W R Mayr, H Partsch, R Neumann, G Stanek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874293     DOI: 10.1016/s0140-6736(86)92089-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

2.  Untreated neuroborreliosis: Bannwarth's syndrome evolving into acute schizophrenia-like psychosis. A case report.

Authors:  U Roelcke; W Barnett; E Wilder-Smith; D Sigmund; W Hacke
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

3.  [Not Available].

Authors:  J Kohler; H Wokalek; U Thoden
Journal:  Schmerz       Date:  1988-03       Impact factor: 1.107

Review 4.  Pathogenesis of Lyme disease.

Authors:  S E Malawista
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

5.  Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome.

Authors:  J H Wokke; P A van Doorn; A Brand; G M Schreuder; M Vermeulen
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

6.  Borrelia burgdorferi infection in Europe: an HLA-related disease?

Authors:  C D Reimers; U Neubert; W Kristoferitsch; K H Pflüger; W R Mayr
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.